The Stargate Project, a $500B initiative focused on artificial intelligence, lifts AI-driven biotech stocks and an unlikely ...

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

A research project will gather data on hellbender populations, which have declined over recent decades and were damaged after ...

A team of researchers from the National University of Singapore (NUS) has developed a novel method to enhance the precision ...

Saliva-based diagnostics have emerged as a transformative approach in medical testing, offering a non-invasive and efficient ...

Most people associate sunburns with DNA damage -- it's what we've been taught in textbooks and by dermatologists for years.

New research reveals that sunburn may be caused by RNA damage, not DNA, challenging long-held beliefs about UV exposure ...

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

The FDA has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta.

This new tool, known as minimal, versatile genetic perturbation technology (mvGPT), combines the powers of gene editing, ...

Moderna (MRNA) stock gained in the premarket after the company received a tender to supply its COVID-19 vaccine in the EU, ...

The Kowalinski group at EMBL Grenoble discovered notable differences between the nuclear cap-binding complex in trypanosomes and humans, a critical component in cellular RNA metabolism. Trypanosomes ...